Physician profile
Randall Robert Mccafferty
NPI 1679672406
$6,779.92
in general payments reported to CMS, 2019-2025
12 companies · $2,122 in 2025
The $2,122 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2020: $22.88 · 2021: $538 · 2022: $2,231 · 2023: $504 · 2024: $118 · 2025: $2,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560 · Travel and Lodging: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.26 |
| Travel and Lodging | $1,183.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $3,196.39 | 2019-2025 | |
| Arthrex, INC. | $1,222.00 | 2025 | |
| Medtronic, INC. | $1,213.13 | 2021-2025 | Cd Horizon Spinal System, Inceptiv, Catalyft Pl Expandable Interbody System |
| Piedmont Plus Innovation | $330.03 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $242.13 | 2022 | |
| Icotec Medical INC. | $181.12 | 2023 | Icotec Blackarmor Spine System |
| Globus Medical, INC. | $144.15 | 2025 | Senza |
| Orthofix Medical, INC. | $143.34 | 2021 | |
| Nuvasive, INC. | $41.18 | 2020-2021 | |
| Cerapedics INC. | $26.04 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Vertex Pharmaceuticals Incorporated | $22.02 | 2025 | |
| Abbott Laboratories | $18.39 | 2025 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Mccafferty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.